Antidepressants and the adolescent brain
The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Abstract
Major unipolar depression is a significant global health problem, with the highest incident risk being during adolescence. A depressive illness during this period is associated with negative long-term consequences including suicide, additional psychiatric comorbidity, interpersonal relationship problems, poor educational performance and poor employment attainment well into adult life. Despite previous safety concerns, selective serotonin reuptake inhibitors (SSRIs) remain a key component of the treatment of moderate to severe depression episodes in adolescents. The impact of SSRIs on the developing adolescent brain, however, remains unclear. In this review we first consider what is currently known about the developing brain during adolescence and how these development processes may be affected by a depressive illness. We then review our understanding of the action of SSRIs, their effects on the brain and how these may differ between adults and adolescents. We conclude that there is currently little evidence to indicate that the human adolescent brain is at developmental risk from SSRIs. Furthermore, there is no clear-cut evidence to support the concerns of marked suicidal adverse side effects accruing in depressed adolescents being treated with SSRIs. Neither, however, is there irrefutable evidence to dismiss all such concerns. This makes SSRI prescribing a matter of medical judgement, ensuring the benefits outweigh the risks for the individual patients, as with so much in therapeutics. Overall, SSRIs show clinical benefits that we judge to outweigh the risks to neurodevelopment and are an important therapeutic choice in the treatment of moderate to severe adolescent depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, the literature suggests that pharmacotherapy can promote neuroplastic changes in the prefrontal cortex, facilitating emotional regulation and social learning [66,67].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [66]
In the citing paper
“This neuronal modulation may be particularly relevant in children with difficulties in processing complex social stimuli [66,67].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [66]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391 · cited 1×
“Indeed, this period has the highest incident risk for affective disorders over the life course (Kessler et al., 2005).”
BackgroundSapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 3×
“ACTH then acts on the adrenal cortex to release glucocorticoids, including cortisol, which itself acts to mobilise energy via intracellular actions (genomic and non-genomic) and prepares the individual metabolically for ‘fight or flight’ responses (Sapolsky et al., 2000).”
BackgroundEpigenetic programming by maternal behavior
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004) · Nature Neuroscience · doi:10.1038/nn1276 · Cited by 6,177
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552 · cited 2×
“In a large, longitudinal study of healthy individuals aged 4–22, Giedd et al. (1999) demonstrated developmental curves for the grey matter of different brain regions.”
BackgroundThe adolescent brain and age-related behavioral manifestations
Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433 · cited 5×
“neuro-maturational changes that have led to adolescence being considered by some authors as a ‘life event’ in itself, making individuals vulnerable to a range of illnesses, including depression (Spear, 2000).”
BackgroundInfluentialRequirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 2×
“Antidepressants, in particular SSRIs, have been shown to increase hippocampal neurogenesis (Boldrini et al., 2012, 2013; Dranovsky and Hen, 2006) and, in rodent models, this has been shown to be necessary for their action (Santarelli et al., 2003), although not sufficient.”
BackgroundRunning increases cell proliferation and neurogenesis in the adult mouse dentate gyrus
van Praag, H., Kempermann, G., & Gage, F. H. (1999) · Nature Neuroscience · doi:10.1038/6368 · Cited by 3,880 · cited 1×
“Factors associated with depression are associated with reduced hippocampal neurogenesis (Dranovsky and Hen, 2006; Mineur et al., 2007), whereas protective factors are associated with increased neurogenesis (Kempermann and Kronenberg, 2003; van Praag et al., 1999).”
BackgroundEpigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & Meaney, M. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2270 · Cited by 3,531 · cited 1×
“In humans, the GR Nr3C1 was found to be hypermethylated in the post-mortem hippocampal tissue from suicide victims only if they had a history of childhood maltreatment (McGowan et al., 2009).”
BackgroundCasey, B. J., Jones, R. M., & Hare, T. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.010 · Cited by 3,345 · cited 1×
“Casey et al. (2008) proposed that it is not how the top-down control systems of the brain develop per se, but how they do so in relation to the bottom-up limbic activating regions, that plays a role.”
Background
Research works printed but not linked: 6
- Hammand T, 2004, Review and evaluation of clinical data
- McKinnon MC, 2009, J Psychiatry Neurosci, 34, 41
- NICE, 2005, Depression in Children and Young People: Identification and Management in Primary, Community and Secondary Care. NICE Clinical Guideline 28
- Sapolsky RM, 2000, Endocr Reviews, 21, 55
- Tottenham N, 2009, Front Hum Neurosci, 3, 68
- World Health Organization, 2011, Global Burden of Mental Disorders and the Need for a Comprehensive, Coordinated Response from Health and Social Sectors at the Country Level. Report by the Secretariat
Cited by
Zhou, X., Teng, T., Zhang, Y., Del Giovane, C., Furukawa, T. A., Weisz, J. R., Li, X., Cuijpers, P., Coghill, D., Xiang, Y., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30137-1 · Cited by 367
New generation antidepressants for depression in children and adolescents: a network meta-analysis
Hetrick, S. E., McKenzie, J. E., Bailey, A. P., Sharma, V., Moller, C. I., Badcock, P. B., Cox, G., Merry, S., & Meader, N. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013674.pub2 · Cited by 269
New generation antidepressants for depression in children and adolescents: a network meta-analysis
Hetrick, S. E., Meader, N., Bailey, A. P., Badcock, P. B., Moller, C. I., Cox, G., Merry, S., & McKenzie, J. E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013674 · Cited by 73
Causes of drug discontinuation in patients with major depressive disorder in China
Zhu, Y., Wu, Z., Sie, O., Cai, Y., Huang, J., Liu, H., Yao, Y., Niu, Z., Wu, X., Shi, Y., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109755 · Cited by 64
The neuroscience and context of adolescent depression
Henje, E., Ho, T. C., Connolly, C. G., LeWinn, K. Z., Sacchet, M. D., Tymofiyeva, O., Weng, H. Y., & Yang, T. T. (2015) · Acta Paediatrica · doi:10.1111/apa.13299 · Cited by 54
“Selective serotonin reuptake inhibitors (SSRIs), which were also originally developed for adult MDD, are now the most commonly used antidepressants for adolescents, even though the effects of SSRIs on brain development are not fully known (17).”
Background
Metadata
- Authors
- Cousins, L., & Goodyer, I. M.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Goodyer, Ian M
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2015-03-05
- Volume
- 29
- Issue
- 5
- Pages
- 545-555
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2143877953
- Cited by
- 61
- References
- 148
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 11 · 2020: 6 · 2019: 9 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 2
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- antidepressants, adolescents, adolescent depression, selective serotonin reuptake inhibitors, brain development, suicide risk, adverse drug reactions, major depressive disorder
- MeSH terms
- Adolescent, Adolescent Behavior, Antidepressive Agents, Brain, Major Depressive Disorder, Humans, Risk Factors, Suicide, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressants and the adolescent brain. https://app.cochat.ai/papers/10.1177/0269881115573542
- The paper
- Cousins, L., & Goodyer, I. M. (2015). Antidepressants and the adolescent brain. Journal of Psychopharmacology. https://doi.org/10.1177/0269881115573542
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.